Pharmacogenomic agreement between two cancer cell line data sets
Top Cited Papers
- 16 November 2015
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 528 (7580), 84-87
- https://doi.org/10.1038/nature15736
Abstract
Large cancer cell line collections broadly capture the genomic diversity of human cancers and provide valuable insight into anti-cancer drug response. Here we show substantial agreement and biological consilience between drug sensitivity measurements and their associated genomic predictors from two publicly available large-scale pharmacogenomics resources: The Cancer Cell Line Encyclopedia and the Genomics of Drug Sensitivity in Cancer databases.Keywords
This publication has 9 references indexed in Scilit:
- Inconsistency in large pharmacogenomic studiesNature, 2013
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Advances in the preclinical testing of cancer therapeutic hypothesesNature Reviews Drug Discovery, 2011
- Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agentsNature Reviews Cancer, 2010
- Predicting drug susceptibility of non–small cell lung cancers based on genetic lesionsJournal of Clinical Investigation, 2009
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanomaNature, 2005